New England Journal of Medicine · 2006 · 409 citations · 11 references
Regenerative MedicineCellular TherapiesMedicineStem Cell ToxicologyStem Cell EngineeringStem Cell ResearchStem Cell PoliciesStem-cell TherapyFda RegulationStem Cell TherapiesStem-cell–based TherapiesDrug AdministrationStem Cell BiologyStem CellsCell BiologyCellular BioengineeringTissue Products
The authors review existing regulations regarding cell and tissue products and discuss how they expect the Food and Drug Administration to apply these regulations to scientists' efforts to develop and test stem-cell–based therapies.
11
Embryonic Stem Cell Lines Derived from Human Blastocysts
James A. Thomson, Joseph Itskovitz‐Eldor, Sander S. Shapiro et al. · Science · 1998 · 15.8K citations
Telomerase Activity, Adult Stem Cell, Biomedical Engineering +16
Michal Amit, Melissa K. Carpenter, Margaret Inokuma et al. · Developmental Biology · 2000 · 1.5K citations
Embryo Culture, Embryonic Stem Cell, Induced Pluripotent Stem Cell +13